![](https://investorshub.advfn.com/uicon/367184.png?cb=1553590500)
Friday, September 08, 2023 9:08:13 AM
Source: Business Wire
Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”), today provides an update with respect to the Company’s Board of Directors (the “Board”) conducting a strategic review of the Company to include implementing a future share repurchase program. The Board is considering and evaluating a share buyback of up to $5,000,000 upon closing and full funding of either (i) the $70,000,000 RC Note with a total draw of $57,000,000; or (ii) the SWAG Agreement for the purchase of a precious gem collection. Both transactions have been previously disclosed.
About Novo Integrated Sciences, Inc.
Novo Integrated Sciences, Inc. is pioneering a holistic approach to patient-first health and wellness through a multidisciplinary healthcare ecosystem of services and product innovation. Novo offers an essential and differentiated solution to deliver, or intend to deliver, these services and products through the integration of medical technology, advanced therapeutics, and rehabilitative science.
We believe that “decentralizing” healthcare, through the integration of medical technology and interconnectivity, is an essential solution to the rapidly evolving fundamental transformation of how non-catastrophic healthcare is delivered both now and in the future. Specific to non-critical care, ongoing advancements in both medical technology and inter-connectivity are allowing for a shift of the patient/practitioner relationship to the patient’s home and away from on-site visits to primary medical centers with mass-services. This acceleration of “ease-of-access” in the patient/practitioner interaction for non-critical care diagnosis and subsequent treatment minimizes the degradation of non-critical health conditions to critical conditions as well as allowing for more cost-effective healthcare distribution.
The Company’s decentralized healt
Recent NVOS News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/13/2024 08:30:34 PM
- Novo Integrated Sciences Receives Confirmation of Issuance of SBLC by HSBC for SBLC Leasing and Monetizing Program • Business Wire • 06/13/2024 08:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/06/2024 07:30:13 PM
- Novo Integrated Sciences’ Board of Directors Approves Increase of Maximum Amount Under Stock Repurchase Program to $10 Million • Business Wire • 06/06/2024 07:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 07:00:19 PM
- Acenzia Selected to Participate in Protein Industries Canada Program to Develop Plant Based Protein Products • Business Wire • 06/05/2024 07:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 07:00:34 PM
- Novo Integrated Sciences and RC Consulting Consortium Group Amend $70,000,000 Promissory Note • Business Wire • 06/03/2024 07:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/31/2024 01:00:14 PM
- Novo Integrated Sciences’ Board of Directors Conducting Strategic Review to Increase Maximum Amount under Stock Repurchase Program • Business Wire • 05/31/2024 01:00:00 PM
- Novo Integrated Sciences Receives Confirmation of Ready, Willing and Able (RWA) Issued by HSBC for SBLC Leasing and Monetizing Program • Business Wire • 05/30/2024 08:30:00 PM
- Novo Integrated Sciences Reports Fiscal Year 2024 Second Quarter Financial Results • Business Wire • 04/15/2024 08:30:00 PM
- Novo Integrated Sciences Closes on $6,210,000 Securities Purchase Agreement • Business Wire • 04/11/2024 09:00:00 PM
- Novo Integrated Sciences Provides Update on Certain Current Actions and Events • Business Wire • 03/26/2024 06:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 09:05:40 PM
- Novo Integrated Sciences Subsidiary, Clinical Consultants International, Signs Agreement with Futura Surgicare Pvt Ltd. • Business Wire • 02/21/2024 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2024 07:00:19 PM
- Novo Integrated Sciences Receives Limited Waiver to Securities Purchase Agreement for $70,000,000 Promissory Note • Business Wire • 02/20/2024 07:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 07:00:26 PM
- Novo Integrated Sciences Appoints New President • Business Wire • 02/16/2024 07:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 10:00:20 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/06/2024 05:00:24 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/22/2024 09:31:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 09:30:12 PM
- Novo Integrated Sciences Reports Fiscal Year 2024 First Quarter Financial Results • Business Wire • 01/22/2024 09:30:00 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM